New SEC Form D filing

Noveome Biotherapeutics, Inc., 2026-08-27

A new SEC Form D private-offering notice from Pittsburgh, PA, a $15,000,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Noveome Biotherapeutics, Inc. site↗ Verified via SEC Form D

Clinical-stage biopharmaceutical company developing ST266, a secretome-based biologic for wound healing, neuroprotection and necrotizing enterocolitis in premature infants.

Filed 2026-08-27Filed to raise $15,000,000First money in 2026-08-12Raised so far $6,750,503HQ (as filed) Pittsburgh, PASector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified noveome.com↗Named in the filing 9 executives & directors
Open this row on the live feed →More new filings in Pennsylvania →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source